Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate.

Patrikainen L, Porvari K, Kurkela R, Hirvikoski P, Soini Y, Vihko P.

Eur J Clin Invest. 2007 Feb;37(2):126-33.

PMID:
17217378
2.

Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.

Wu GJ, Varma VA, Wu MW, Wang SW, Qu P, Yang H, Petros JA, Lim SD, Amin MB.

Prostate. 2001 Sep 15;48(4):305-15.

PMID:
11536311
3.

Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.

Jing C, El-Ghany MA, Beesley C, Foster CS, Rudland PS, Smith P, Ke Y.

J Natl Cancer Inst. 2002 Apr 3;94(7):482-90.

4.

Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells.

Liu T, Bauskin AR, Zaunders J, Brown DA, Pankhurst S, Russell PJ, Breit SN.

Cancer Res. 2003 Aug 15;63(16):5034-40. Erratum in: Cancer Res. 2004 Jan 15;64(2):220. Panhurst, S [corrected to Pankhurst, S].

5.

Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression.

Vaarala MH, Porvari K, Kyllönen A, Vihko P.

Lab Invest. 2000 Aug;80(8):1259-68.

PMID:
10950117
6.

The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome.

Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ, Johnen H, Russell PJ, Barret W, Stricker PD, Grygiel JJ, Kench JG, Henshall SM, Sutherland RL, Breit SN.

Cancer Res. 2005 Mar 15;65(6):2330-6.

7.
8.

Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia.

Kakehi Y, Segawa T, Wu XX, Kulkarni P, Dhir R, Getzenberg RH.

Prostate. 2004 Jun 1;59(4):351-6.

PMID:
15065082
10.

Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.

Wei H, Desouki MM, Lin S, Xiao D, Franklin RB, Feng P.

Mol Cancer. 2008 Jan 21;7:7. doi: 10.1186/1476-4598-7-7.

12.

Dysregulated expression of MIC-1/PDF in human prostate tumor cells.

Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF, Batra SK.

Biochem Biophys Res Commun. 2003 Jun 6;305(3):598-604.

PMID:
12763036
14.

Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues.

Nakamura T, Scorilas A, Stephan C, Yousef GM, Kristiansen G, Jung K, Diamandis EP.

Br J Cancer. 2003 Apr 7;88(7):1101-4.

15.

Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.

Halvorsen OJ, Oyan AM, Bø TH, Olsen S, Rostad K, Haukaas SA, Bakke AM, Marzolf B, Dimitrov K, Stordrange L, Lin B, Jonassen I, Hood L, Akslen LA, Kalland KH.

Int J Oncol. 2005 Feb;26(2):329-36.

PMID:
15645116
16.

Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.

Jiborn T, Abrahamson M, Gadaleanu V, Lundwall A, Bjartell A.

BJU Int. 2006 Jul;98(1):189-96.

17.
18.

A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.

Kaushal A, Myers SA, Dong Y, Lai J, Tan OL, Bui LT, Hunt ML, Digby MR, Samaratunga H, Gardiner RA, Clements JA, Hooper JD.

Prostate. 2008 Mar 1;68(4):381-99. doi: 10.1002/pros.20685.

PMID:
18196551
19.

Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.

Rosner IL, Ravindranath L, Furusato B, Chen Y, Gao C, Cullen J, Sesterhenn IA, McLeod DG, Srivastava S, Petrovics G.

Urology. 2007 Dec;70(6):1225-9.

PMID:
18158066
20.

Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.

Rasiah KK, Kench JG, Gardiner-Garden M, Biankin AV, Golovsky D, Brenner PC, Kooner R, O'neill GF, Turner JJ, Delprado W, Lee CS, Brown DA, Breit SN, Grygiel JJ, Horvath LG, Stricker PD, Sutherland RL, Henshall SM.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):711-6.

Items per page

Supplemental Content

Write to the Help Desk